| 1 | 13:20-13:30 |
Opening Remarks |
|
|||||
| 1 | 13:30-14:00 |
Frontiers in the Management of Advanced Prostate Cancer: Current Insights and Future Perspectives |
|
|||||
| 1 | 14:00-14:05 |
Interactive Introduction |
|
|||||||||||
| 2 | 14:05-14:15 |
Chief Complaint, Present Illness, Examinations and Treatment Course |
|
|||||||||||
| 3 | 14:15-14:20 |
Audience Poll |
|
|||||||||||
| 4 | 14:20-14:30 |
Interactive Discussion-Which Tasks Can Be Handed Over to AI and Which Must Remain with Clinicians? |
|
|||||||||||
| 5 | 14:30-14:35 |
AI Scenario Demonstration |
|
|||||||||||
| 6 | 14:35-14:45 |
Expert Comments-Efficacy Verification of AI-Assisted Diagnosis and Treatment for Prostate Cancer |
|
|||||||||||
| 1 | 14:45-14:50 |
Case Presentation--Chief Complaint, Present Illness, Examinations and Treatment Course |
|
|||||||||||
| 2 | 14:50-15:00 |
Audience Poll |
|
|||||||||||
| 3 | 15:00-15:10 |
Interactive Discussion-Which Tasks Can Be Handed Over to AI and Which Must Remain with Clinicians? |
|
|||||||||||
| 4 | 15:10-15:15 |
AI Scenario Demonstration |
|
|||||||||||
| 5 | 15:15-15:25 |
Expert Comments-Efficacy Verification of AI-Assisted Diagnosis and Treatment for Prostate Cancer |
|
|||||||||||
| 1 | 15:25-15:30 |
Summary |
|
|||||
| 1 | 15:30-15:35 |
Opening Video |
|||||||||||||||
| 2 | 15:35-15:40 |
Opening Remarks |
|
||||||||||||||
| 1 | 15:40-16:00 |
The Role of Blue Light in TURBT: An International Perspective |
|
||||||||||||||
| 2 | 16:00-16:20 |
Clinical Value of Blue Light: Guidelines and Chinese Expert Consensus |
|
||||||||||||||
| 3 | 16:20-16:35 |
Discussion (3 Topics) |
|
||||||||||||||
| 1 | 16:35-16:50 |
Current Clinical Practice in China |
|
||||||||||||||
| 2 | 16:50-17:10 |
Combined Procedures Using Blue-Light Cystoscopy: Clinical Practice and Case Reviews |
|
||||||||||||||
| 3 | 17:10-17:25 |
Discussion (3 Topics) |
|
||||||||||||||
| 4 | 17:25-17:30 |
Summary |
|
||||||||||||||